Novel therapy for Hodgkin lymphoma: reports in the 55th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2014.01.003
- VernacularTitle:霍奇金淋巴瘤治疗新进展:第55届美国血液学会年会报道
- Author:
Meng WU
;
Jun ZHU
- Publication Type:Journal Article
- Keywords:
Hodgkin lymphoma;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2014;23(1):5-6,8
- CountryChina
- Language:Chinese
-
Abstract:
The 55th ASH annual meeting published a special report about Hodgkin lymphoma,which mainly contains management of early-stage Hodgkin lymphoma,novel targeted therapy and the optimal treatment of lymphocyte-predominant Hodgkin lymphoma.The therapy of Hodgkin lymphoma should be individualized,in order to improve both PFS and OS.More clinical trials should be designed on the target therapy and the treatment strategy of nodular lymphocyte-predominant Hodgkin lymphoma.
